Niki BiosolutionsNIKI
13F holders, Q3 2024 (September 30)2holders −2
0new positions
2sold out
$1.79avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($71K) and Morgan Stanley ($29K).
- Company
- Niki Biosolutions Inc.
- Filed as
- APTORUM GROUP LIMITED (Q3 2024)
- CUSIP
- G6096M122
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $107K |
All 13F filers, Q2 2024 → Q3 2024: 4,450 shares bought and 24,635 shares sold, net −20,185 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Geode Capital Management, LLC | 0.00% | Reduce -0.5% | 39,662 | $71K |
| Morgan Stanley | 0.00% | Add +38.7% | 15,960 | $29K |
"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.